02898.HK
Sunho Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 6.40
+0.00%Margins
Gross margin
100.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-17.1%
Return on equity
-14.7%
Return on assets
-16.3%
Return on invested capital
0.00x
Asset turnover
HKD 13.1M
Cash from operations
HKD 3.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025